CLDI Stock Analysis Overview
What this means: InvestorsObserver gives Calidi Biotherapeutics Inc (CLDI) an overall rank of 30, which is below average. Calidi Biotherapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 30 means that 70% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
CLDI Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
CLDI Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
CLDI Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
CLDI Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
CLDI Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
CLDI Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
CLDI Stock Analysis Overview
What this means: InvestorsObserver gives Calidi Biotherapeutics Inc (CLDI) an overall rank of 30, which is below average. Calidi Biotherapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 30 means that 70% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.